Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS PFIZER IPCA LABS/
PFIZER
 
P/E (TTM) x 51.7 38.2 135.4% View Chart
P/BV x 5.4 6.0 89.9% View Chart
Dividend Yield % 0.3 1.7 19.4%  

Financials

 IPCA LABS   PFIZER
EQUITY SHARE DATA
    IPCA LABS
Mar-23
PFIZER
Mar-23
IPCA LABS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0624,662 22.8%   
Low Rs7683,407 22.5%   
Sales per share (Unadj.) Rs243.0530.0 45.8%  
Earnings per share (Unadj.) Rs19.4136.4 14.2%  
Cash flow per share (Unadj.) Rs29.7159.4 18.6%  
Dividends per share (Unadj.) Rs4.0070.00 5.7%  
Avg Dividend yield %0.41.7 25.2%  
Book value per share (Unadj.) Rs230.3701.0 32.8%  
Shares outstanding (eoy) m253.7045.75 554.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.87.6 49.5%   
Avg P/E ratio x47.229.6 159.5%  
P/CF ratio (eoy) x30.825.3 121.7%  
Price / Book Value ratio x4.05.8 69.0%  
Dividend payout %20.651.3 40.2%   
Avg Mkt Cap Rs m232,120184,576 125.8%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8763,317 388.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64224,248 254.2%  
Other income Rs m1,5181,011 150.2%   
Total revenues Rs m63,16025,258 250.1%   
Gross profit Rs m9,0338,420 107.3%  
Depreciation Rs m2,6161,055 247.9%   
Interest Rs m482135 357.5%   
Profit before tax Rs m7,4538,240 90.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5342,001 126.6%   
Profit after tax Rs m4,9196,239 78.8%  
Gross profit margin %14.734.7 42.2%  
Effective tax rate %34.024.3 140.0%   
Net profit margin %8.025.7 31.0%  
BALANCE SHEET DATA
Current assets Rs m51,89324,933 208.1%   
Current liabilities Rs m18,0586,574 274.7%   
Net working cap to sales %54.975.7 72.5%  
Current ratio x2.93.8 75.8%  
Inventory Days Days5193 54.8%  
Debtors Days Days62 256.4%  
Net fixed assets Rs m34,33613,780 249.2%   
Share capital Rs m254458 55.5%   
"Free" reserves Rs m58,16731,616 184.0%   
Net worth Rs m58,42032,073 182.1%   
Long term debt Rs m6,5180-   
Total assets Rs m86,22939,031 220.9%  
Interest coverage x16.562.1 26.5%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.70.6 115.1%   
Return on assets %6.316.3 38.4%  
Return on equity %8.419.5 43.3%  
Return on capital %12.226.1 46.8%  
Exports to sales %42.92.8 1,511.8%   
Imports to sales %13.30 38,294.2%   
Exports (fob) Rs m26,434688 3,843.3%   
Imports (cif) Rs m8,1788 97,351.2%   
Fx inflow Rs m26,434688 3,843.3%   
Fx outflow Rs m8,1788 97,351.2%   
Net fx Rs m18,257679 2,687.2%   
CASH FLOW
From Operations Rs m8,0583,557 226.6%  
From Investments Rs m-7,250-361 2,011.1%  
From Financial Activity Rs m5,072-3,458 -146.7%  
Net Cashflow Rs m5,881-262 -2,247.9%  

Share Holding

Indian Promoters % 46.3 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 44.8 18.2 246.4%  
FIIs % 10.3 3.0 338.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 36.1 148.9%  
Shareholders   82,809 112,456 73.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Pfizer Share Price Performance

Period IPCA Labs Pfizer S&P BSE HEALTHCARE
1-Day 3.35% -4.80% 1.18%
1-Month 4.27% -8.24% -0.75%
1-Year 56.49% 21.78% 61.82%
3-Year CAGR 9.46% -2.07% 18.16%
5-Year CAGR 20.88% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.